In 2023, Michael C. Greiner earned $723.26K in total compensation at Avanos Medical, including $390.25K salary and $333.01K bonus. Most recently acquired 68,632 shares in Mar 2025. Currently holds stock worth $2.80M.
Compensation History
Annual executive compensation data for Michael C. Greiner, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$723.26K
Salary
$390.25K
Bonus
$333.01K
Other
$0.00
Salary
$390.25KBoard Justification
The compensation program is designed to align executive pay with performance metrics that drive company success, ensuring that compensation reflects both individual and company performance.
Bonus
$333.01KBoard Justification
Annual cash incentive payout based on performance metrics achieved in 2023, resulting in an 84.7% payout percentage.
Other Compensation
$0.00Board Justification
No additional compensation reported outside of salary, bonus, and stock awards.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus was on performance-based awards that will vest in future years.
Performance Metrics
Performance metrics for 2023 included adjusted net sales, adjusted EBITDA, and strategic initiatives.
Michael C. Greiner
Ex-CEO of Avanos Medical
Education
Not specified
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
January 1, 1972 - 53 years ago
CEO of Avanos Medical for
0 years 5 months (Oct 2024 - Apr 2025)
Previous Experience
CFO at AngioDynamics, Inc.
Holdings
Track Michael C. Greiner's stock holdings and portfolio value over time.
Total Stock Sold
$193.94K
$42.10K
1,939 ANGO shares
$151.84K
8,000 AVNS shares
What if they kept their stock?
If Michael C. Greiner didn't sell their stock, today they would have:
Extra ANGO1,939 shares worth $26.12K and AVNS8,000 shares worth $90.08K.
This is -40.08% and $77.74K less than what they got when they sold the stock.
Insider Trading
Michael C. Greiner's recent stock transactions, purchases, and sales filed with the SEC.
68,632 shares
AVNS
Mar 7, 2025
Received
10,000 shares
AVNS
Dec 3, 2024
Received
44,189 shares
AVNS
Oct 29, 2024
Received
$153.08K
AVNS at $19.13/share
Mar 14, 2024
Sale
$1.10M
AVNS at $19.14/share
Mar 6, 2024
Received
36,350 shares
AVNS
Mar 6, 2023
Received
34,619 shares
AVNS
Mar 6, 2023
Received
30,575 shares
AVNS
Mar 4, 2022
Received
$750.07K
AVNS at $47.29/share
Mar 17, 2021
Received
$1.13M
AVNS at $30.67/share
May 7, 2020
Received
Rivals
Compare Michael C. Greiner with competitor CEOs and industry peers.